Document is current

Article History

Received: 11 February 2022

Revised: 8 July 2022

Accepted: 8 August 2022

First Online: 16 August 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name of institute/committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual.participants included in the study.

: Dr. Westover is a co-founder of Beacon Biosignals and reports grants from NIH, during the conduct of the study; Dr. Cash reports other COI from Neuralink, Paradromics, and Synchron, and Beacon Biosignals, outside the submitted work. Dr. Thomas reports personal fees from GLG Councils, Guidepoint Global, and Jazz Pharmaceutics, outside the submitted work. In addition, Dr. Thomas has a patent ECG-spectrogram with royalties paid by MyCardio, LLC, a patent Auto-CPAP with royalties paid by DeVilbiss-Drive, and an unlicensed patent CO2 device for central/complex sleep apnea issued. Dr. Thompson reports consulting for Bayer, Novartis, and Thetis, outside the submitted work. In addition, Dr. Kuller has a patent: Patent US10123724B2 “Breath volume monitoring system and method” issued. Dr. Kuller reports non-financial support from Myair Inc., during the conduct of the study, and non-financial support from Myair Inc, outside the submitted work.